Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02064283 · ClinicalTrials.gov registry record · NA

Early Assessment of Treatment Response Using Functional Diffusion Mapping

A NA study of Prostate Cancer, sponsored by University of Michigan Rogel Cancer Center.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT02064283 is a NA study of Prostate Cancer that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 20 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02064283, a NA study of Prostate Cancer, has completed, sponsored by University of Michigan Rogel Cancer Center.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study will evaluate the feasibility of identifying changes in diffusion MRI characteristics of bone that correlates with response to therapy in men with metastatic prostate cancer.

Conditions Studied

Prostate Cancer

Interventions

  • PROCEDURE Diffusion MRI

Study Locations (1)

Michigan

  • The University of Michigan Comprehensive Cancer Center - Ann Arbor

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2007-05
Est. Completion 2012-10
Phase NA

Sponsor

University of Michigan Rogel Cancer Center

292 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02064283

The ClinicalTrials.gov registry entry for NCT02064283 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (97% lower). The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which Diffusion MRI is the first listed.

NCT02064283 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT02064283 about?

NCT02064283 is a clinical study titled "Early Assessment of Treatment Response Using Functional Diffusion Mapping". This study will evaluate the feasibility of identifying changes in diffusion MRI characteristics of bone that correlates with response to therapy in men with metastatic prostate cancer.

What is the current status of trial NCT02064283?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2007-05. Estimated completion is 2012-10.

What conditions does trial NCT02064283 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT02064283?

The interventions under investigation include: Diffusion MRI (PROCEDURE).

Who is sponsoring clinical trial NCT02064283?

This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02064283 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.